Tempest Therapeutics shares head back to earth after 4,000% gain
October 12, 2023 at 12:49 PM EDT
Oncology company's stock drops more than 50% as it seeks partners to help advance investigational cancer treatment.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|